** 7 Days Left ** One Health Next Generation CGM Will Transform Diabetes Care 

INVEST HERE: (https://wefunder.com/onehealthbiosensing).

We didn’t invent CGM, but we are re-defining it.

The One Health CGM (continuous glucose monitor) is at the forefront of diabetes care and enables pain-free, needle-free glucose sensing in a daily disposable patch. We combined that with multi-modal sensing capabilities like heart rate monitoring, sleep tracking, activity tracking and the potential for multi-analyze sensing like ketones, lactic acid, and urea. It represents the next generation of CGM, it’s real, and we couldn’t be prouder.

No one could have predicted that in an International Diabetes Federation event this past month it was estimated that in 2024, 589 million people (1 in 9) on the planet have diabetes. It was estimated that the cost of treating these people in 2024 exceeded $1 trillion USD representing 12% of all global health expenditures. It is estimated that this population and the cost to treat them will grow almost 50% to 850 million people and $2 trillion USD.

CGM has proven to be one of the most effective and powerful tools in the arsenal for people to manage, treat, and reverse their diabetes, but less than 5% of people with diabetes have access to CGM. 

Join us NOW, or increase your investment NOW, on the journey to transform the lives of every single person on the planet with diabetes and be part of our success. This effort to include our community will end in one week. 

INVEST HERE: (https://wefunder.com/onehealthbiosensing). 

With gratitude and warm regards in good health,

Jeff Dachis

CEO, Founder

One Health Biosensing Inc.

jeff@onehealthbiosensing.com

Follow us here:

Instagram: https://instagram.com/onehealthbiosensing/

Facebook: https://facebook.com/profile.php?id=61566557262015

LinkedIn: https://linkedin.com/company/one-health-biosensing/

X/Twitter: https://x.com/OneHealthBio

URL: https://onehealthbiosensing.com